Call for proposals for the Innovative Medicine Initiative


The Innovative Medicines Initiative (IMI) has launched its 1st Call for proposals under IMI 2.

The Call for proposals represents an excellent opportunity for researchers to take part in ground-breaking collaborative projects that aim to deliver tangible benefits for patients. Scientists from academia, industry, SMEs, medium-sized companies, hospitals and patients' organisations are warmly invited to get involved in our projects.

This Call features two topics:

  • Translational approaches to disease modifying therapy of Type 1 Diabetes Mellitus (T1DM)
  • Discovery and validation of novel endpoints in dry age-related macular degeneration and diabetic retinopathy

Deadline for submitting Expressions of Interest (EoIs)

12 November 2014 – 17:00 CET

Find out more

The Call text, as well as details of how to apply, can be found on the Call web page.


From 11 to 15 July 2014 IMI will hold webinars on each Call topic and on IMI 2 rules and procedures. For more information and to register please visit the webinar page.

Find partners for submitting a proposal

Search for project partners via the Partner Search Tool.

More information:

More information about IMI and this Call for proposals can be found in the attached flyer and on the IMI website

This website is built with Eplica CMS